FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306177066> ?p ?o ?g. }

• W4306177066 endingPage "81" @default.
• W4306177066 startingPage "76" @default.
• W4306177066 abstract "This prospective clinical study aimed to determine the efficacy and prognostic factors of adoptive activated αβT lymphocyte immunotherapy for various refractory cancers. The primary endpoint was overall survival (OS), and the secondary endpoint was radiological response.The authors treated 96 patients. Activated αβT lymphocytes were infused every 2 weeks for a total of six times. Prognostic factors were identified by analyzing clinical and laboratory data obtained before therapy.Median survival time (MST) was 150 days (95% confidence interval, 105-191), and approximately 20% of patients achieved disease control (complete response + partial response + stable disease). According to the multivariate Cox proportional hazards model with Akaike information criterion-best subset selection, sex, concurrent therapy, neutrophil/lymphocyte ratio, albumin, lactate dehydrogenase, CD4:CD8 ratio and T helper (Th)1:Th2 ratio were strong prognostic factors. Using parameter estimates of the Cox analysis, the authors developed a response scoring system. The authors then determined the threshold of the response score between responders and non-responders. This threshold was able to significantly differentiate OS of responders from that of non-responders. MST of responders was longer than that of non-responders (317.5 days versus 74 days). The validity of this response scoring system was then confirmed by internal validation.Adoptive activated αβT lymphocyte immunotherapy has clinical efficacy in certain patients. The authors' scoring system is the first prognostic model reported for this therapy, and it is useful for selecting patients who might obtain a better prognosis through this modality." @default.
• W4306177066 created "2022-10-14" @default.
• W4306177066 creator A5000508958 @default.
• W4306177066 creator A5004495981 @default.
• W4306177066 creator A5006420235 @default.
• W4306177066 creator A5025981434 @default.
• W4306177066 creator A5026278665 @default.
• W4306177066 creator A5047404508 @default.
• W4306177066 creator A5049130190 @default.
• W4306177066 creator A5066123249 @default.
• W4306177066 creator A5084105797 @default.
• W4306177066 creator A5087651102 @default.
• W4306177066 date "2023-01-01" @default.
• W4306177066 modified "2023-09-30" @default.
• W4306177066 title "Prospective study of adoptive activated αβT lymphocyte immunotherapy for refractory cancers: development and validation of a response scoring system" @default.
• W4306177066 cites W1982453726 @default.
• W4306177066 cites W2005041705 @default.
• W4306177066 cites W2007702854 @default.
• W4306177066 cites W2014415110 @default.
• W4306177066 cites W2017381571 @default.
• W4306177066 cites W2033658212 @default.
• W4306177066 cites W2052261395 @default.
• W4306177066 cites W2068273212 @default.
• W4306177066 cites W2074703669 @default.
• W4306177066 cites W2094670432 @default.
• W4306177066 cites W2099657378 @default.
• W4306177066 cites W2106671991 @default.
• W4306177066 cites W2214799754 @default.
• W4306177066 cites W2282962877 @default.
• W4306177066 cites W2487029284 @default.
• W4306177066 cites W2581283430 @default.
• W4306177066 cites W2621280624 @default.
• W4306177066 cites W2740883959 @default.
• W4306177066 cites W2792066576 @default.
• W4306177066 cites W2918416998 @default.
• W4306177066 cites W2955949220 @default.
• W4306177066 cites W3032578076 @default.
• W4306177066 cites W3034365591 @default.
• W4306177066 cites W3104254817 @default.
• W4306177066 cites W3117470571 @default.
• W4306177066 cites W3130718611 @default.
• W4306177066 doi "https://doi.org/10.1016/j.jcyt.2022.09.007" @default.
• W4306177066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36253253" @default.
• W4306177066 hasPublicationYear "2023" @default.
• W4306177066 type Work @default.
• W4306177066 citedByCount "0" @default.
• W4306177066 crossrefType "journal-article" @default.
• W4306177066 hasAuthorship W4306177066A5000508958 @default.
• W4306177066 hasAuthorship W4306177066A5004495981 @default.
• W4306177066 hasAuthorship W4306177066A5006420235 @default.
• W4306177066 hasAuthorship W4306177066A5025981434 @default.
• W4306177066 hasAuthorship W4306177066A5026278665 @default.
• W4306177066 hasAuthorship W4306177066A5047404508 @default.
• W4306177066 hasAuthorship W4306177066A5049130190 @default.
• W4306177066 hasAuthorship W4306177066A5066123249 @default.
• W4306177066 hasAuthorship W4306177066A5084105797 @default.
• W4306177066 hasAuthorship W4306177066A5087651102 @default.
• W4306177066 hasBestOaLocation W43061770661 @default.
• W4306177066 hasConcept C121608353 @default.
• W4306177066 hasConcept C126322002 @default.
• W4306177066 hasConcept C143998085 @default.
• W4306177066 hasConcept C188816634 @default.
• W4306177066 hasConcept C203014093 @default.
• W4306177066 hasConcept C203092338 @default.
• W4306177066 hasConcept C2777701055 @default.
• W4306177066 hasConcept C2777761686 @default.
• W4306177066 hasConcept C38180746 @default.
• W4306177066 hasConcept C44249647 @default.
• W4306177066 hasConcept C50382708 @default.
• W4306177066 hasConcept C535046627 @default.
• W4306177066 hasConcept C71924100 @default.
• W4306177066 hasConceptScore W4306177066C121608353 @default.
• W4306177066 hasConceptScore W4306177066C126322002 @default.
• W4306177066 hasConceptScore W4306177066C143998085 @default.
• W4306177066 hasConceptScore W4306177066C188816634 @default.
• W4306177066 hasConceptScore W4306177066C203014093 @default.
• W4306177066 hasConceptScore W4306177066C203092338 @default.
• W4306177066 hasConceptScore W4306177066C2777701055 @default.
• W4306177066 hasConceptScore W4306177066C2777761686 @default.
• W4306177066 hasConceptScore W4306177066C38180746 @default.
• W4306177066 hasConceptScore W4306177066C44249647 @default.
• W4306177066 hasConceptScore W4306177066C50382708 @default.
• W4306177066 hasConceptScore W4306177066C535046627 @default.
• W4306177066 hasConceptScore W4306177066C71924100 @default.
• W4306177066 hasIssue "1" @default.
• W4306177066 hasLocation W43061770661 @default.
• W4306177066 hasLocation W43061770662 @default.
• W4306177066 hasOpenAccess W4306177066 @default.
• W4306177066 hasPrimaryLocation W43061770661 @default.
• W4306177066 hasRelatedWork W1980569034 @default.
• W4306177066 hasRelatedWork W1998259048 @default.
• W4306177066 hasRelatedWork W2361700749 @default.
• W4306177066 hasRelatedWork W2892601847 @default.
• W4306177066 hasRelatedWork W2902684922 @default.
• W4306177066 hasRelatedWork W3089163820 @default.
• W4306177066 hasRelatedWork W3093444689 @default.
• W4306177066 hasRelatedWork W3095136102 @default.
• W4306177066 hasRelatedWork W3112877994 @default.

• next